Patents by Inventor Stephen Martin

Stephen Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220355659
    Abstract: A utility vehicle includes an exhaust assembly fluidly coupled to an engine. Depending on various parameters, such as the size and/or performance of the vehicle, the exhaust assembly is required to meet certain emissions regulations. Such emissions regulations may be met by increasing the temperature within the exhaust assembly, however, at particularly high temperatures, a catalyst of the exhaust assembly may be damaged. Therefore, the exhaust assembly includes various options for cooling portions thereof to remove heat from the assembly.
    Type: Application
    Filed: May 3, 2022
    Publication date: November 10, 2022
    Inventors: Michael A. Purdy, Ryan D. Carlson, Ralph W. Lauzze, III, Ryan M. Lacanne, Jake A. Stafford, Stephen Martin
  • Publication number: 20220309286
    Abstract: Methods, systems, and computer-readable media for generating a statistically covaried machine learning model for performance measurement of service providers. The method receives a configuration file that includes one or more parameters associated with a plurality of individuals and parses it to generate and executing the database query on input data to generate sets of tabulated data of individuals of the plurality of individuals. The method next determines one or more measures of service providers listed in the configuration file using two or more tabulated data of individuals from the sets of tabulated data of individuals. The method finally generates a covaried machine learning model by training a machine learning model by statistically covarying measures and using them as training data.
    Type: Application
    Filed: January 13, 2022
    Publication date: September 29, 2022
    Applicant: Includede Health, Inc.
    Inventors: Nathaniel Freese, Meera Rao, Rick Wolf, Peyton Rose, Stephen Martin, Sameer Soi, Zachary Taylor, Ye Wang
  • Publication number: 20220193026
    Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
    Type: Application
    Filed: March 14, 2022
    Publication date: June 23, 2022
    Inventors: Vincent Jacob Kalish, Frederick Arthur Brookfield, Stephen Martin Courtney, Lisa Marie Frost, John P. Toscano
  • Patent number: 11315202
    Abstract: A facility for representing home attribute values for a plurality of homes and a plurality of home attributes is described. The facility incorporates a data structure comprising, for each of the plurality of homes, for each of the plurality of attribute value sources, the capacity to store values for any of the plurality of home attributes obtained from the attribute value source.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: April 26, 2022
    Assignee: Zillow, Inc.
    Inventors: Timothy VanderMey, Fred Farhad Sadaghiani, Stephen Martin McNamee, Marcin Szuster, Chloe Linden Harford, Jeffrey Thomas Brinker, Randy Winston Puttick
  • Patent number: 11306056
    Abstract: The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: April 19, 2022
    Assignees: Cardioxyl Pharmaceuticals, Inc., The Johns Hopkins University
    Inventors: John P. Toscano, Frederick Arthur Brookfield, Andrew D. Cohen, Stephen Martin Courtney, Lisa Marie Frost, Vincent Jacob Kalish
  • Patent number: 11304924
    Abstract: The present disclosure provides nitroxyl donating pharmaceutical compositions comprising N-substituted hydroxylamine derivatives. The compositions are highly efficacious in treating cardiovascular diseases (e.g., heart failure), have a suitable toxicological profile, and are sufficiently stable for intravenous or oral administration.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: April 19, 2022
    Assignee: Cardioxyl Pharmaceuticals, Inc.
    Inventors: Vincent Jacob Kalish, John Reardon, Frederick Arthur Brookfield, Stephen Martin Courtney, Lisa Marie Frost, John P. Toscano
  • Patent number: 11273143
    Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: March 15, 2022
    Assignee: Cardioxyl Pharmaceuticals, Inc.
    Inventors: Vincent Jacob Kalish, Frederick Arthur Brookfield, Stephen Martin Courtney, Lisa Marie Frost, John P. Toscano
  • Publication number: 20220020489
    Abstract: A computer-implemented method for inferring a condition of at least one analytical device based on at least one automatic notification received over a network from the analytical device is disclosed. The method comprises receiving, at a data processing agent, at least one automatic notification from at least one analytical device, processing, at the data processing agent, the at least one automatic notification, to thus identify one or more characteristics of the at least one automatic notification from the at least one analytical device, inferring, at the data processing agent, the condition of the at least one analytical device, by applying the one or more identified characteristics to a model; and generating, at the data processing agent, a notification reporting the inferred condition of the analytical device.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 20, 2022
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Stephen Martin, Jakub Winiarz, Alexandra Paun
  • Patent number: 11227184
    Abstract: Methods, systems, and computer-readable media for generating a statistically covaried machine learning model for performance measurement of service providers. The method receives a configuration file that includes one or more parameters associated with a plurality of individuals and parses it to generate and executing the database query on input data to generate sets of tabulated data of individuals of the plurality of individuals. The method next determines one or more measures of service providers listed in the configuration file using two or more tabulated data of individuals from the sets of tabulated data of individuals. The method finally generates a covaried machine learning model by training a machine learning model by statistically covarying measures and using them as training data.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: January 18, 2022
    Assignee: GRAND ROUNDS, INC.
    Inventors: Nathaniel Freese, Meera Rao, Rick Wolf, Peyton Rose, Stephen Martin, Sameer Soi, Zachary Taylor, Ye Wang
  • Publication number: 20220006746
    Abstract: A computer implemented method and associated apparatus, networked system, computer readable medium, and computer program element are presented. The computer-implemented method generates a message filter configuration based on a message priority indication received from a first analyzer network. The first analyzer network comprises at least one analytical device configured to generate a message. The method comprises receiving, at a data processing agent, a message priority indication indicating a priority assigned to the message in the first analyzer network, providing, at the data processing agent, at least one message filter configuration based on the message priority indication of the message, and communicating the message filter configuration, or a portion thereof, to a second analyzer network comprising a second analytical device.
    Type: Application
    Filed: June 28, 2021
    Publication date: January 6, 2022
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Stephen Martin, Alexandra Paun, Jakub Winiarz
  • Publication number: 20210348338
    Abstract: An aqueous barrier coat for formable cellulosic substrates comprises a blend of A) at least one aqueous polymer binder dispersion at 40 wt % to 95 wt %, B) at least one active filler at 3 wt % to 30 wt % and, C) one or more optional additives, such as wetting additives, dispersants, thickeners, defoamers, and crosslinkers. Crystallinity is present in at least one of the polymer binder dispersion and active filler particle. The resulting dried film has a shear storage modulus between 50° C. and 60° C. in the range of 1.5×106 to 1×109 Pascals, a shear storage modulus between 80° C. and 90° C. in the range of 2×105 to 5×107 Pascals, and a shear storage modulus between 100° C. and 110° C. is in the range of 5×103 to 1×106 Pascals. The total weight % of crystalline polymer binder and the crystalline active filler combined is greater than 50%.
    Type: Application
    Filed: February 18, 2021
    Publication date: November 11, 2021
    Inventors: Anshyang LIN, Stephen MARTIN, Carmen PANTO, JR., Grant SCHUTTE
  • Publication number: 20210295958
    Abstract: A method for operating a data processing agent for processing data from an automated medical sample analyzer is presented. The method comprises receiving at least one automated analyzer status datum transmitted from at least one automated analyzers in a medical sample analysis system to the data processing agent, wherein the automated analyzer status data is generated by the at least one automated analyzer in response to an automated analyzer condition detected by an automated analyzer, receiving at least one annotation datum at the data processing agent, associating at least one automated analyzer status datum with at least one annotation datum using the processing agent to generate an automated analyzer system data record, and outputting the automated analyzer system data record from the data processing agent, wherein the automated analyzer system data record comprises at least one automated analyzer device status datum associated with at least one annotation datum.
    Type: Application
    Filed: March 15, 2021
    Publication date: September 23, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Stephen Martin, Alexandra Paun, Jakub Winiarz
  • Patent number: 11088524
    Abstract: A protective apparatus for a distribution line conductor includes an elongate tube configured to be installed on the conductor and a plurality of annular members concentrically positioned on the tube and configured to rotate independently of each other. The tube has a longitudinal axis and defines a longitudinally extending chamber configured to receive the conductor. The tube has opposite first and second ends and a longitudinally extending opening from the first end to the second end that facilitates installation of the elongate tube on the conductor. Each annular member includes an outer surface and a plurality of circumferentially-spaced apart members extending outwardly from the outer surface. Each annular member includes a longitudinally extending slot that is configured to align with the longitudinally extending opening of the tube to facilitate installation of the elongate tube and the plurality of annular members as an assembly on the conductor.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: August 10, 2021
    Inventors: Laura Jackson Hiller, David Edwin Bowling, Stephen Martin Parker, Luis Puigcerver
  • Publication number: 20210168124
    Abstract: A method for processing data of an analytical instrument for analyzing biological samples is presented. The method comprises receiving instrument data from the analytical instrument at a data processing module communicatively connected with the analytical instrument, generating metadata from the received instrument data at the data processing module, applying a first encryption to the instrument data at the data processing module, applying a second encryption to the generated metadata at the data processing module, and transmitting the encrypted metadata and encrypted instrument data to a remote server. The remote server and the data processing module are communicatively connected. The method also comprises removing the second encryption from the metadata at the remote server and forwarding the instrument data encrypted by the first encryption from the remote server to a management system of the analytical instrument.
    Type: Application
    Filed: January 19, 2021
    Publication date: June 3, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Urs Suter, Alejandro Morcillo Montejo, Antonio Tienda Fernandez, Stephen Martin
  • Patent number: 10938793
    Abstract: A method for processing data of an analytical instrument for analyzing biological samples is presented. The method comprises receiving instrument data from the analytical instrument at a data processing module communicatively connected with the analytical instrument, generating metadata from the received instrument data at the data processing module, applying a first encryption to the instrument data at the data processing module, applying a second encryption to the generated metadata at the data processing module, and transmitting the encrypted metadata and encrypted instrument data to a remote server. The remote server and the data processing module are communicatively connected. The method also comprises removing the second encryption from the metadata at the remote server and forwarding the instrument data encrypted by the first encryption from the remote server to a management system of the analytical instrument.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: March 2, 2021
    Assignee: Roche Diagnostics Operations, Inc
    Inventors: Urs Suter, Alejandro Morcillo Montejo, Antonio Tienda Fernandez, Stephen Martin
  • Publication number: 20210053915
    Abstract: The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
    Type: Application
    Filed: November 9, 2020
    Publication date: February 25, 2021
    Inventors: John P. Toscano, Frederick Arthur Brookfield, Andrew D. Cohen, Stephen Martin Courtney, Lisa Marie Frost, Vincent Jacob Kalish
  • Patent number: 10931921
    Abstract: Techniques to provide a micro-broadcast of an event are described. Video data streams of a live event at a venue may be captured in one or more wireless camera devices. The data streams may be sent to one of a network of wireless access points where they are relayed to a control center. A computer system in the control center may select one of the video data streams to be broadcast as a micro-broadcast. The selected video data stream may then be formatted for the micro-broadcast before a micro-broadcast transmitter broadcasts the formatted selected video data stream.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: February 23, 2021
    Assignee: CBS Interactive Inc.
    Inventors: Bruce Goldfeder, Stephen Martin Milton
  • Publication number: 20210015784
    Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
    Type: Application
    Filed: October 5, 2020
    Publication date: January 21, 2021
    Inventors: Vincent Jacob Kalish, Frederick Arthur Brookfield, Stephen Martin Courtney, Lisa Marie Frost, John P. Toscano
  • Patent number: 10829445
    Abstract: The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: November 10, 2020
    Assignees: Cardioxyl Pharmaceuticals, Inc., The Johns Hopkins University
    Inventors: John P. Toscano, Frederick Arthur Brookfield, Andrew D. Cohen, Stephen Martin Courtney, Lisa Marie Frost, Vincent Jacob Kalish
  • Patent number: 10792273
    Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: October 6, 2020
    Assignee: Cardioxyl Pharmaceuticals, Inc.
    Inventors: Vincent Jacob Kalish, Frederick Arthur Brookfield, Stephen Martin Courtney, Lisa Marie Frost, John P. Toscano